Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis [PDF]
, 2005 Transforming growth factor-beta (TGF-beta) plays a crucial role in the pathogenesis of skin fibrotic diseases. Systemic TGF-beta inhibitors effectively inhibit fibrosis in different animal models; however, systemic inhibition of TGF-beta raises important
Borras-Cuesta, F. (Francisco) +8 more
core
Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma [PDF]
, 2020 Emily Mirizio +7 more
openalex +1 more source
Systematic Review of
, 2023 Luis Fernando Sánchez‐Espino +5 more
openalex +1 more source
Barriers to Care in Juvenile Localized and Systemic Scleroderma: An Exploratory Survey Study of Caregivers’ Perspectives [PDF]
, 2023 Leigh A. Stubbs +19 more
openalex +1 more source
Clinical appearance of skin lesions and disturbances of pigmentation in localized scleroderma
, 1984 Jørgen Serup
openalex +2 more sources
Hyaluronic Acid Filler Injection for Localized Scleroderma - Case Report and Review of Literature on Filler Injections for Localized Scleroderma. [PDF]
Clin Cosmet Investig Dermatol, 2022 Sharad J.
europepmc +1 more source
Topical Photodynamic Therapy for Localized Scleroderma
, 2000 Sigrid Karrer +3 more
openalex +1 more source
Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study [PDF]
, 2018 Alina Skrzypek‐Salamon +3 more
openalex +1 more source